The International Clinical Mass Spectrometry Society held in San Diego, USA for the clinical excellence of PapilloTyper, which has the world's highest genotypic resolution as a cervical cancer diagnosis product, and PapilloPredict, a new tumor antigen diagnostic agent. Introduced in MSACL (Mass Spectrometry: Application to the Clinical Lab) 2014. We received interest and praise from major multinational molecular diagnostic medical device companies and leading US clinical laboratory, and we decided to build an active cooperative relationship to advance into overseas markets.
We discussed product cooperation and development cooperation with BioMerieux, a leading company in the field of microbial diagnostics, in France, Thermo Fisher, the world's largest mass spectrometry and diagnostic equipment company, and Bruker, a representative mass spectrometer.
Meanwhile, in order to effectively advance into the overseas clinical market, we visited the Virgin instruments corporation in Boston, USA, which possesses the core technology in the field of mass spectrometry equipment, and conducted on-site technical evaluation. In order to do so, we decided to accelerate our joint research.